CPRiL

Casp9

caspase 9

Enables cysteine-type peptidase activity. Involved in several processes, including response to anesthetic; response to indole-3-methanol; and response to ischemia. Located in cytoplasm. Used to study pre-malignant neoplasm. Biomarker of several diseases, including alcohol use disorder; brain disease (multiple); heart disease (multiple); kidney disease (multiple); and neurodegenerative disease (multiple). Human ortholog(s) of this gene implicated in several diseases, including Parkinson's disease; colorectal cancer; lung non-small cell carcinoma; pancreatic cancer; and type 2 diabetes mellitus. Orthologous to human CASP9 (caspase 9). [provided by Alliance of Genome Resources, Jun 2025]

• caspase-9
• 25 kDa caspase-9 dominant negative protein
• Ice-like apoptotic protease 6
apoptotic protease Mch-6
apoptotic protease activating factor 3
caspase 9, apoptosis-related cysteine peptidase
caspase-9 dominant negative form
caspase-9-carboxyl-terminal divergent
Apaf3
Casp-9-CTD
Casp9_v1
Ice-Lap6
Mch6